Reviewing Aimei Health Technology (AFJK) and Its Rivals

Aimei Health Technology (NASDAQ:AFJK) is one of 89 publicly-traded companies in the “UNCLASSIFIED” industry, but how does it contrast to its peers? We will compare Aimei Health Technology to related companies based on the strength of its risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.

Earnings & Valuation

This table compares Aimei Health Technology and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	52.52
Aimei Health Technology Competitors	$41.37 million	-$18.54 million	93.19

Aimei Health Technology’s peers have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Aimei Health Technology has a beta of -0.02, suggesting that its share price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s peers have a beta of -0.08, suggesting that their average share price is 108% less volatile than the S&P 500.

Profitability

This table compares Aimei Health Technology and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Aimei Health Technology and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	0	1	0	0	2.00
Aimei Health Technology Competitors	225	265	217	3	2.00

As a group, “UNCLASSIFIED” companies have a potential upside of 96.81%. Given Aimei Health Technology’s peers higher probable upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its peers.

Institutional & Insider Ownership

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Comparatively, 42.9% of shares of all “UNCLASSIFIED” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Aimei Health Technology peers beat Aimei Health Technology on 9 of the 13 factors compared.

Aimei Health Technology Company Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.